secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHEMED CORP (CHE)
CIK:        0000019584
Form:       8-K
Filed at:   2024-04-24T23:59:59+00:00
Accession:  0001562762-24-000096
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemed Q1 2024: Adjusted EPS $5.20 beats; VITAS EBITDA surges 67%, Roto-Rooter down 16%
--------------------------------------------------------------------------------

- Revenue +5.2% to $589.2M; GAAP EPS $4.24 (+18.4%); Adjusted EPS $5.20 (+21.5%)
- VITAS net patient revenue +14% to $354M, ADC up 10.3% to 19,665; adjusted EBITDA +67.2% to $60.7M
- Roto-Rooter revenue -5.8% to $235.2M, adjusted EBITDA -15.6% to $60.7M; margin down 299bps
- Acquired Covenant Health hospice assets for $85M on Apr 17; no debt, $313.4M cash; bought back 50k shares for $32.3M
- Full-year 2024 adjusted EPS guidance reaffirmed at $23.30-$23.70; next update with Q2 results

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/19584/000156276224000096/0001562762-24-000096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/19584/000156276224000096/che-20240424x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-24-000096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer